Mark Identification

ONCOLYTIC IMMUNOTHERAPY

Serial Number

98452032

Filing Date

Mar 15, 2024

Trademark by

CG ONCOLOGY INC.

Classification Information

Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing

Pharmaceuticals

Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders; immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders

Computer and Scientific